118 related articles for article (PubMed ID: 31455339)
1. ELQ-331 as a prototype for extremely durable chemoprotection against malaria.
Smilkstein MJ; Pou S; Krollenbrock A; Bleyle LA; Dodean RA; Frueh L; Hinrichs DJ; Li Y; Martinson T; Munar MY; Winter RW; Bruzual I; Whiteside S; Nilsen A; Koop DR; Kelly JX; Kappe SHI; Wilder BK; Riscoe MK
Malar J; 2019 Aug; 18(1):291. PubMed ID: 31455339
[TBL] [Abstract][Full Text] [Related]
2. Alkoxycarbonate Ester Prodrugs of Preclinical Drug Candidate ELQ-300 for Prophylaxis and Treatment of Malaria.
Frueh L; Li Y; Mather MW; Li Q; Pou S; Nilsen A; Winter RW; Forquer IP; Pershing AM; Xie LH; Smilkstein MJ; Caridha D; Koop DR; Campbell RF; Sciotti RJ; Kreishman-Deitrick M; Kelly JX; Vesely B; Vaidya AB; Riscoe MK
ACS Infect Dis; 2017 Oct; 3(10):728-735. PubMed ID: 28927276
[TBL] [Abstract][Full Text] [Related]
3. Long-acting intramuscular injections of ELQ-331, an antimalarial agent.
Karunakaran D; Mutyam SK; Fu M; Chen J; Pham KHN; Pou S; Winter RW; Nilsen A; Dodean RA; Smilkstein MJ; Riscoe MK; Shankar G
Eur J Pharm Sci; 2024 Jul; 198():106795. PubMed ID: 38729224
[TBL] [Abstract][Full Text] [Related]
4. ELQ-300 prodrugs for enhanced delivery and single-dose cure of malaria.
Miley GP; Pou S; Winter R; Nilsen A; Li Y; Kelly JX; Stickles AM; Mather MW; Forquer IP; Pershing AM; White K; Shackleford D; Saunders J; Chen G; Ting LM; Kim K; Zakharov LN; Donini C; Burrows JN; Vaidya AB; Charman SA; Riscoe MK
Antimicrob Agents Chemother; 2015 Sep; 59(9):5555-60. PubMed ID: 26124159
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cytochrome bc1 as a strategy for single-dose, multi-stage antimalarial therapy.
Stickles AM; Ting LM; Morrisey JM; Li Y; Mather MW; Meermeier E; Pershing AM; Forquer IP; Miley GP; Pou S; Winter RW; Hinrichs DJ; Kelly JX; Kim K; Vaidya AB; Riscoe MK; Nilsen A
Am J Trop Med Hyg; 2015 Jun; 92(6):1195-201. PubMed ID: 25918204
[TBL] [Abstract][Full Text] [Related]
6. Atovaquone and ELQ-300 Combination Therapy as a Novel Dual-Site Cytochrome bc1 Inhibition Strategy for Malaria.
Stickles AM; Smilkstein MJ; Morrisey JM; Li Y; Forquer IP; Kelly JX; Pou S; Winter RW; Nilsen A; Vaidya AB; Riscoe MK
Antimicrob Agents Chemother; 2016 Aug; 60(8):4853-9. PubMed ID: 27270285
[TBL] [Abstract][Full Text] [Related]
7. Orally Bioavailable Endochin-Like Quinolone Carbonate Ester Prodrug Reduces Toxoplasma gondii Brain Cysts.
Doggett JS; Schultz T; Miller AJ; Bruzual I; Pou S; Winter R; Dodean R; Zakharov LN; Nilsen A; Riscoe MK; Carruthers VB
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32540978
[TBL] [Abstract][Full Text] [Related]
8. 3-Position Biaryl Endochin-like Quinolones with Enhanced Antimalarial Performance.
Pou S; Winter RW; Dodean RA; Liebman K; Li Y; Mather MW; Nepal B; Nilsen A; Handford MJ; Riscoe TM; Laxson S; Kirtley PJ; Aleshnick M; Zakharov LN; Kelly JX; Smilkstein MJ; Wilder BK; Kortagere S; Vaidya AB; Alday PH; Doggett JS; Riscoe MK
ACS Infect Dis; 2024 Jun; ():. PubMed ID: 38862127
[TBL] [Abstract][Full Text] [Related]
9. Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial.
Gaur AH; McCarthy JS; Panetta JC; Dallas RH; Woodford J; Tang L; Smith AM; Stewart TB; Branum KC; Freeman BB; Patel ND; John E; Chalon S; Ost S; Heine RN; Richardson JL; Christensen R; Flynn PM; Van Gessel Y; Mitasev B; Möhrle JJ; Gusovsky F; Bebrevska L; Guy RK
Lancet Infect Dis; 2020 Aug; 20(8):964-975. PubMed ID: 32275867
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of Two New Endochin-like Quinolones, ELQ-596 and ELQ-650, in Experimental Mouse Models of Human Babesiosis.
Vydyam P; Chand M; Pou S; Winter RW; Liebman KM; Nilsen A; Doggett JS; Riscoe MK; Ben Mamoun C
ACS Infect Dis; 2024 Apr; 10(4):1405-1413. PubMed ID: 38563132
[TBL] [Abstract][Full Text] [Related]
11. The gender-related variability in the pharmacokinetics and antiplasmodial activity of naphthoquine in rodents.
Xie Y; Liu H; Sun Y; Xing J
Malar J; 2020 Feb; 19(1):71. PubMed ID: 32054478
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal, but not polyclonal, antibodies protect against Plasmodium yoelii sporozoites.
Charoenvit Y; Mellouk S; Cole C; Bechara R; Leef MF; Sedegah M; Yuan LF; Robey FA; Beaudoin RL; Hoffman SL
J Immunol; 1991 Feb; 146(3):1020-5. PubMed ID: 1988490
[TBL] [Abstract][Full Text] [Related]
13. Effects of the antimalarial drugs ferroquine and artesunate on Plasmodium yoelii yoelii gametocytegenesis and vectorial transmission.
Mustfa K; Landau I; Chabaud AG; Chavatte JM; Chandenier J; Duong TH; Richard-Lenoble D
Sante; 2011; 21(3):133-42. PubMed ID: 22294247
[TBL] [Abstract][Full Text] [Related]
14. The effect of macrophage and angiogenesis inhibition on the drug release and absorption from an intramuscular sustained-release paliperidone palmitate suspension.
Darville N; van Heerden M; Mariën D; De Meulder M; Rossenu S; Vermeulen A; Vynckier A; De Jonghe S; Sterkens P; Annaert P; Van den Mooter G
J Control Release; 2016 May; 230():95-108. PubMed ID: 27067365
[TBL] [Abstract][Full Text] [Related]
15. Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment.
Belnoue E; Costa FT; Frankenberg T; Vigário AM; Voza T; Leroy N; Rodrigues MM; Landau I; Snounou G; Rénia L
J Immunol; 2004 Feb; 172(4):2487-95. PubMed ID: 14764721
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium liver load following parenteral sporozoite administration in rodents.
Ploemen IH; Chakravarty S; van Gemert GJ; Annoura T; Khan SM; Janse CJ; Hermsen CC; Hoffman SL; Sauerwein RW
Vaccine; 2013 Jul; 31(34):3410-6. PubMed ID: 23063834
[TBL] [Abstract][Full Text] [Related]
17. Radical cure of experimental babesiosis in immunodeficient mice using a combination of an endochin-like quinolone and atovaquone.
Lawres LA; Garg A; Kumar V; Bruzual I; Forquer IP; Renard I; Virji AZ; Boulard P; Rodriguez EX; Allen AJ; Pou S; Wegmann KW; Winter RW; Nilsen A; Mao J; Preston DA; Belperron AA; Bockenstedt LK; Hinrichs DJ; Riscoe MK; Doggett JS; Ben Mamoun C
J Exp Med; 2016 Jun; 213(7):1307-18. PubMed ID: 27270894
[TBL] [Abstract][Full Text] [Related]
18. Plasmodium yoelii nigeriensis (MDR)-efficacy of oral pyronaridine against multidrug-resistant malaria in Swiss mice.
Tripathi R; Umesh A; Mishra M; Puri SK; Dutta GP
Exp Parasitol; 2000 Mar; 94(3):190-3. PubMed ID: 10831384
[TBL] [Abstract][Full Text] [Related]
19. A plant-derived morphinan as a novel lead compound active against malaria liver stages.
Carraz M; Jossang A; Franetich JF; Siau A; Ciceron L; Hannoun L; Sauerwein R; Frappier F; Rasoanaivo P; Snounou G; Mazier D
PLoS Med; 2006 Dec; 3(12):e513. PubMed ID: 17194195
[TBL] [Abstract][Full Text] [Related]
20. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH
J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
